Here comes a me-too anti-PD-L1 for #BladderCancer. But wait, 0% ORR for PD-L1- patients? https://t.co/LQWMU9iU45 @Uroweb #UrologyWeek

Here comes a me-too anti-PD-L1 for #BladderCancer. But wait, 0% ORR for PD-L1- patients? https://t.co/LQWMU9iU45 @Uroweb #UrologyWeek

Posted: 30/09/2016